Insights On Upstream Manufacturing

31. Effective Supply Chain And QC Testing Through Collaborative Partnerships 9/30/2025

    Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.

32. Advancing Non-Viral Gene Editing With Enhanced Post-Electroporation Performance 9/22/2025

    Non-viral gene editing is a powerful method for cell therapy. Learn how to address key challenges like cell viability and thermal damage with an innovative approach designed to improve performance.

33. It's Never Too Late To Intensify: Upstream Process Intensification 9/21/2025

    Explore how early upstream intensification, flexible facility design, and smart technology choices can reduce costs, improve scalability, and support sustainability in low-volume protein therapy production.

34. How Next-Gen Cell Line Development Improves Your Chances Of Clinical Success 9/18/2025

    Examine five essential features of an effective CLD platform and how they can help address common development challenges in antibody and recombinant vaccine programs.

35. AbZelectPRO™: Enhanced Cell Line Development Platform 9/17/2025

    Leveraging Abzena’s deep expertise in biologics development and supported by our comprehensive analytics suite, AbZelectPRO™ streamlines the IND application pathway, ensuring smooth progression into clinical phases.

36. A Beginner's Guide To Mesenchymal Stem Cell Culture 9/16/2025

    Gain a foundational understanding of the process for culturing mesenchymal stem cells in stirred-tank bioreactors and learn about the key parameters for successful scale-up.

37. A New Transfection System Tailored For Optimized AAV Production 9/14/2025

    In AAV manufacturing, long-term success depends not just on titers, but on maximizing the percentage of full capsids to ensure efficacy, safety, and scalability.

38. The CHO Toolkit: Flexible Solutions For Complex Molecules 9/11/2025

    A modular cell line development platform helps overcome biologic complexity. Learn how flexibility and expert support drive success from early development through commercial manufacturing.

39. The Growing Role Of MSCs In Regenerative Medicine 9/10/2025

    Mesenchymal stem cells (MSCs) show great promise in regenerative medicine, but scaling their production for clinical use is a key challenge that requires careful optimization and planning.

40. The Hidden Cost Of Off-The-Shelf Media In Cell Therapy 9/10/2025

    Generic, off-the-shelf media can introduce hidden costs and delays in cell and gene therapy development. A strategic media approach is a critical advantage that can accelerate your path to the clinic.